Tesamorelin
,

Tesamorelin

Price range: $100.00 through $150.00

GHRH Analog

SKU: N/A Categories: ,

GHRH ANALOG RESEARCH COMPOUND

Tesamorelin is a research-grade synthetic analog of human Growth Hormone-Releasing Hormone (GHRH), comprising the full GHRH(1–44) sequence with a trans-3-hexenoic acid modification at the N-terminus for enhanced stability. Studied in preclinical GH axis, metabolic, and adipose tissue research models.

SPECIFICATIONS

PURITY
99%+ COA Verified

FORM
Lyophilized Powder

STORAGE
−20°C

VIAL SIZE
10mg / 20mg

TECHNICAL DETAILS

Sequence / Composition (trans-3-hexenoic acid)-GHRH(1–44)-NH₂
Molecular Weight 5135.88 g/mol
CAS Number 218949-48-9
Certificate of Analysis Included with every order
Third-Party Tested HPLC + Mass Spectrometry
Shipping Plain unmarked packaging · 1–2 days
Research Use Only. This product is intended for in vitro laboratory and pre-clinical research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified researchers only.
📦
Packaging
Shipped in sealed, nitrogen-purged vials with tamper-evident caps. Discreet outer packaging on every order.
🧊
Shipping & Storage
Shipped with cold packs where required. Store at -20°C upon receipt. Stable for 24 months when properly stored.
⚗️
Research Use Only
For in vitro and laboratory research only. Not intended for human or veterinary use. Handle per standard lab safety protocols.
🔬
Reconstitution
Reconstitute with bacteriostatic water or sterile saline. Use within 28 days once reconstituted and refrigerate at 4°C.
📄
Documentation
Full Certificate of Analysis included. Batch number, HPLC report, and mass spec data available on request.
🚚
Dispatch
Orders dispatched within 24 hours on business days. Tracked shipping to US addresses. International shipping available.

Peer-Reviewed Research

Tesamorelin - Sources & References

All citations from accredited peer-reviewed journals. No vendor blogs or promotional content.

01
Growth Hormone and Tesamorelin in the Management of HIV-Associated Lipodystrophy
Journal of the International AIDS Society · 2011 - PMC3218714
Grunfeld C, et al.
View Study →
02
Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy
Drugs · 2012 - DOI: 10.2165/11209710-000000000-00000
Rasmussen MH.
View Study →
03
Effect of Tesamorelin on Liver Fat and Visceral Fat in HIV-Infected Patients: A Randomized Clinical Trial
JAMA Internal Medicine · 2015 - PMC4363137
Falutz J, et al.
View Study →
04
Tesamorelin Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
AIDS Research and Human Retroviruses · 2019 - PMC6766405
View Study →
05
Body Composition, Hepatic Fat, Metabolic Outcomes of Tesamorelin: Meta-Analysis of Randomized Controlled Trials
PubMed - Meta-Analysis · 2025 - PMID: 41545261
View Study →

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *

Related products

Shopping Cart
Scroll to Top